Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Archipelago Ventures is a venture capital and impact investment firm rather than a drug developer, CRO, pharma, or healthcare operating company. The firm focuses on circular-economy and materials-transition investments, backing deep-tech startups working across supply chains such as plastics and polymers, textiles and fibres, metals, and recycling-related infrastructure. Public descriptions of the firm emphasize sustainable value creation, decarbonisation, and improved material efficiency rather than therapeutic R&D. Although some third-party databases tag healthcare among covered sectors, the company’s own positioning is centered on climate, materials, and industrial innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Archipelago Ventures.